Dexmedetomidine Unknown Status Phase Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0050052 (Dexmedetomidine)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04358627Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients
NCT04127500The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac SurgeryTreatment
NCT03927963The Neuroprotection Effect of DexmedetomidineOther